Sendai virus: Illuminating parainfluenza virus dynamics in living animals Charles J. Russell, PhD postdoc: Crystal Burke, PhD Funding: NIAID R01AI083370.

Slides:

Advertisements

Similar presentations

Pathogenesis and Control of Viral Infections Chapter 30.

Advertisements

Infection in COPD Pulmonology Subspeciality Rounds (12/11/2008)Dr.Krock Dr.Vysetti Dr.Vysetti.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian virus Vaccine 2007 Huoying Shi, Xiu Fan Liu, Xiaorong Zhang,

Common Communicable Diseases

Respiratory Syncytial Virus is the leading cause of respiratory tract infection in infants in the United States and worldwide. There is currently no vaccine.

Adriana Weinberg, MD University of Colorado Denver.

Lessons Learned from the Reconstruction of the 1918 Pandemic Adolfo García-Sastre, PhD Professor of Microbiology Mount Sinai School of Medicine.

The Antiviral Activity of Oseltamivir against H5N1 Human A/Vietnam/1203/04 and A/Turkey/15/06 Influenza Viruses in Ferrets Elena Govorkova, N.A. Ilyushina,

ANIMAL MODELS HIV Cure Research Training Curriculum The HIV CURE training curriculum is a collaborative project aimed at making HIV cure research science.

Wendy Vuong Joseph Martin del Campo Reza Parhizkar Micro 401.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Bacterial Physiology (Micr430) Lecture 18 Bacterial Pathogenesis (Based on other textbooks such as Madigan’s)

General Microbiology (Micr300)

DR MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Viral infection of the respiratory tract -- 2.

Bloodborne Pathogens HIV, AIDS, and Hepatitis Unit 1.

EPIDEMIOLOGY AND PREVENTION OF INFLUENZA. Introduction Unique epidemiology: – Seasonal attack rates of 10% to 30% – Global epidemics Influenza viruses.

EPIDEMIOLOGY AND PREVENTION OF INFLUENZA. Introduction Unique epidemiology: – Seasonal attack rates of 10% to 30% – Global pandemics Influenza viruses.

MEASLES RUBEOLA OR MORBILLI Department of infectious disease WANG JINGYAN.

The Common COld By damian verbakel. What is the disease? The common cold is a viral infectious disease The common cold is also know as; nasopharyngitis,

PESTIVIRUSES PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College, Royal College Street,

Supplemental Figure 1 Tissue: ColorectumLungsVaginal wall Route: ICRIN IVAG IVAG (Depo) Dose: 2x10 9 5x10 8 1x Luc RLU (log10)

Influenza: Pathogenesis Overview ● Entry Route ● Infection Cycle ● Virulence ● Clinical Course ● Complications ● Factors.

Towards a small animal model for hepatitis C Alexander Ploss & Charles M. Rice EMBO reports (2009) 10, Abteilung und/oder Titel Datum.

Phylogenetic relationship of lentiviruses. - The heterologous host all develop disease that show many parallels to human AIDS, the similarities including.

ACKNOWLEDGMENTS USD Animal Resource Center Jonathan A. McCullers (St. Jude Children’s Research Hospital) for providing viruses SD-BRIN Undergraduate Fellows.

Luciferase Based Plasmid Reporter System for the Detection and Quantification of Human Respiratory Syncytial Virus Group 14: Oral Report 4, 3/13/08 Melanie.

Influenza Today Joseph Mester, Ph.D. September 24, 2009.

Paramyxoviruses 副黏液病毒. Objectives How many types of viruses under paramyxovirus. How many serotypes of each virus? What is the status of Hemagglutinin.

Respiratory viruses (other than influenza virus).

CORONAVIRUSES PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College, Royal College.

ANIMAL MODELS FOR HIV VACCINES Girish N. Vyas, Ph.D. UCSF School of Medicine, San Francisco (UCSF) A quote from the keynote Address at the January, 2008.

ENTEROVIRUSES Family: Small, spherical, Icosahedral, Single stranded RNA.

DR. MOHAMMED ARIF ASSOCIATE PROFESSOR CONSULTANT VIROLOGIST HEAD OF THE VIROLOGY UNIT Mumps (parotitis)

MUMPS VIRUS Genus Rubulavirus. PARAMYXOVIRIDAE Paramyxovirinae Genus respirovirus: Genus Rubulavirus Genus morbillivirus Pneumovirinae Genus Pneumovirus.

John R. LaMontagne Memorial Symposium on Pandemic Influenza Research April 4-5, 2005 Institute of Medicine Working Group Five: Immunology, Assay Standardization,

Pathology - the scientific study of the nature of disease and its causes A PATHOGEN is any disease causing agent. Quick Exercise: How many diseases can.

Introduction to Virology

ORTHOMYXOVIRIDAE- INFLUENZA VIRUSES PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College,

MEASLES (RUBEOLA) VIRUS Genus Morbillivirus. PARAMYXOVIRIDAE Paramyxovirinae Genus respirovirus: Genus Rubulavirus Genus morbillivirus Pneumovirinae Genus.

1 INFLUENZA VIRUS. 2 ‘FLU’ True influenza –influenza virus A or influenza virus B (or influenza virus C infections - much milder) Febrile (showing signs.

paramyxo.ppt Paramyxoviruses paramyxo.ppt.

Viruses causing respiratory infections. Influenza viruses

Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.

TODAY Tuberculosis can affect any part of the body although it is usually found in the lungs as these are the first site of infection. It kills approximately.

MEASLES RUBEOLA OR MORBILLI Department of infectious disease.

1 IMMUNE CORRELATES OF PROTECTION AGAINST INFLUENZA A VIRUSES IN SUPPORT OF PANDEMIC VACCINE DEVELOPMENT FDA/NIH/WHO Public Workshop, December 10-11, 2007.

MEASLES Dr. R.N.Roy, Associate Professor, Community Medicine.

The paramyxoviruses include the most important agents of respiratory infections of infants and young children (respiratory syncytial virus and the parainfluenza.

PARAMYXOVIRIDAE PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College, Royal College.

VIRAL INFECTIONS OF THE RESPIRATORY TRACT DR. JEYAKUMAR NELSON UNIT OF MICROBIOLOGY MBBS ( BATCH-17)

Immune System and Disease Chapter 35. Nonspecific Defenses  The human body faces against many dangerous enemies  Harmful bacteria, viruses, fungi, and.

Lecture 35: Common Viral Diseases DR. N. JEYAKUMAR UNIT OF MICROBIOLOGY MBBS ( BATCH-17)

Virology – Pathogenesis of viral infections JU- 2 nd Year Medical Students By Dr Hamed AlZoubi – Microbiology and Immunology Department – Mutah University.

Anti-influenza activity of dihydroquercetin from Larix sibirica (L.) on the model of lethal influenza virus infection. Zarubaev V.V. †, Garshinina A.V.

1 University of Texas San Antonio Update on F. tularensis attenuated vaccine strain construction and evaluation TVD Team 2/19/08 tech call.

Human parainfluenza viruses are the etiologic agents causing 'human parainfluenza.' hPIVs are a group of four distinct serotypes of enveloped single stranded.

Respiratory Viruses Respiratory diseases occur most frequently in colder weather, especially in raining season, and in cases of overcrowding. Causes of.

A PATHOGEN is any disease causing agent.

Pulmonary Tuberculosis (TB)

Infectious Bronchitis

Influenza Vaccines MedCh 401 Lecture 5 19May06 KL Vadheim Lecture 4.

Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets

Clinical Microbiology and Infection

Volume 22, Issue 1, Pages e4 (July 2017)

(A) Weight loss curves following intranasal infection of different mouse groups with COBRA, seasonal, or pandemic influenza viruses. (A) Weight loss curves.

Prevention of Genital Herpes Simplex Virus Type 1 and 2 Disease in Mice Immunized with a gD-Expressing Dominant-Negative Recombinant HSV-1 Richard Brans,

Volume 22, Issue 1, Pages (January 2014)

Host Parasite Relationship

Role of Research in Prevention

A CD3 gate B C D Supplementary Figure 1. Characterization of airway cells for transfer. BALB/c mice were infected twice with 105 pfu RSV with 21 day recovery.

Presentation transcript:

Sendai virus: Illuminating parainfluenza virus dynamics in living animals Charles J. Russell, PhD postdoc: Crystal Burke, PhD Funding: NIAID R01AI083370

HPIV1, HPIV2, HPIV3 leading cause of pediatric hospitalization (21,000/yr in USA) virtually all infected by age 5; reinfections common but usually less severe no available anti-PIV drugs or vaccines Paramyxoviruses replicate in epithelial cells that line the respiratory tract, causing inflammation in the nasopharynx, larnyx, trachea & lungs Important causes of croup (laryngotracheobronchitis) and pneumonia Human parainfluenza viruses

Cross-protective immune responses (Jennerian vaccine) Tracheal infection/inflammation (croup) Efficient contact transmission Reinfection can occur Majority of healthy hosts do not suffer severe LRT infection Lamb & Kolakofsky, 2001 Fields Virology Sendai virus: murine counterpart of HPIV1

NPMFHNL luciferase WT-like reporter virus: MF* optimize gene start sequence Burke…Russell 2011 PLoS Pathogens

Imaging infection daily in a living mouse PFU M-F* in 30 μl day: lungs highest lowest Burke…Russell 2011 PLoS Pathogens

Bioluminescence in NasopharynxBioluminescence in Lungs Weight Change Resistant in lungs but susceptible in URT Burke…Russell 2011 PLoS Pathogens

Nasopharynx Lungs Weight loss Low-dose inoculation grows to high level in URT 7000 PFU 70 PFU Burke…Russell 2011 PLoS Pathogens

day post infection 70 or 7000 PFU, BALB/c or 129 mice luminescence 1º infection or transmission luminescence reinfection 3x10 6 PFU challenge 30 Contact transmission

70 PFU or 7000 PFU virus “resistant” BALB/c “susceptible” 129 mice 100% contact transmission similar-looking URT-biased infection in recipients protects from lethal challenge

1. Nasopharynx 2. Trachea (~0.8 days later) 3. Lungs (~1.0 days later) For both 129/SvJ and BALB/c mouse strains and 70- or 7,000-PFU inoculations into donors highest lowest Progression of 1° infection in contact recipient mice

3.4 days3.3 days 7,000 PFU inoculation Susceptibility to lung infection does not affect contact transmission. Nasal virus shedding in inoculated mice => contact transmission. Time until detection in nasopharynx

Looks like a low-dose, low-volume, URT-biased infection nasopharynxtrachealungs 70 PFU in 5  L Contact transmission Burke…Russell 2013 PLoS Pathogens

donors isolated recipients Air flow 129-strain “susceptible” mice 7.6 or 15 cm Airborne transmission day of expt primary challenge 30 3x10 6 PFU Burke…Russell 2013 PLoS Pathogens

(4/21) (5/21) (8/21) Working hypothesis: Dynamics of infection determined by the site of inoculation & infectious dose Diverse dynamics of primary infection after airborne transmission day: Burke…Russell 2013 PLoS Pathogens

1° infection inversely correlates with reinfection Nasal first 4/21 No transmission 3/21 Tracheal dominant 8/21 Tracheal first 5/21 Burke…Russell 2013 PLoS Pathogens

Protection from natural reinfection by contact transmission Intranasal vaccination with a low dose/volume of attenuated virus: no reinfection. Intramuscular vaccination: reinfection in the nasopharynx and trachea. Burke…Russell 2014 submitted

Decoupling of Sendai virus infection in upper versus lower respiratory tract Lung infection and concomitant host response determines pathogenesis Upper respiratory tract infection determines transmission & induces protective immunity even under suboptimal conditions Clinical diagnosis: titers from nasal washes not same as lung titers Vaccine development: attenuated or lower-dose I.N. live-virus vaccines Paradigm for respiratory virus infection: for a virus matched to its host, ‘natural’ infection after transmission elicits immunity without pathology Robust upper respiratory tract infection benefits both virus and the host Mode of transmission determines the tropism and magnitude of primary infection, which is in turn inversely correlated with reinfection ANISOTROPIC INFECTIONS: Dynamics of natural respiratory infections can vary. Compartmentalization of immune response contributes to protection from reinfection Major Findings

Sendai virus: Illuminating parainfluenza virus dynamics in living animals Charles J. Russell, PhD postdoc: Crystal Burke, PhD Funding: NIAID R01AI083370